News
-
Removes limits
Thursday | May 4 2023FROM 01 Jun, prescribing of oral ivermectin for 'off-label' uses will no longer be limited to specialists such as dermatologists, gastroenterologists and infectious diseases specialists, the TGA has stated.
-
-
Embed into aged care
Wednesday | May 3 2023THE Commonwealth Government's Medical Research Future Fund recently invested $1.5m into investigating how pharmacists can work with other healthcare professionals to implement the new Department of Health and Aged Care Guiding Principles for Medication Management in Residential Aged Care Facilities.
-
First Optometrist Warehouse opens
Wednesday | May 3 2023CHEMIST Warehouse Co-Founder Jack Gance was joined by Optometrist Warehouse Managing Directors and optometry veterans Charles Hornor and Peter Larsen (pictured), to celebrate the official opening of Optometrist Warehouse's first store over the weekend with a ribbon cutting in Malvern, Victoria.
-
Priceline kicks up a pink
Wednesday | May 3 2023PRICELINE Pharmacy has successfully trademarked the magenta Pantone, joining a prestigious club of iconic brands in Australia that've secured trademarks for their signature colour, including Cadbury, Tiffany, and Australia Post.
-
Get started in research
Wednesday | May 3 2023THE world of academic research is closer than ever for more Australian pharmacists and technicians with the Society of Hospital Pharmacists of Australia (SHPA) yesterday introducing a new category to its flagship journal and launching a suite of resources and publishing opportunities to support residents, technicians and early career pharmacists.
-
More choice
Wednesday | May 3 2023NOVA Pharmaceuticals offers more choice to pharmacists and customers at attractive price points.
-
UTI trial decried
Wednesday | May 3 2023THE Royal Australian College of General Practitioners in its Senate Committee submission warns that expanding pharmacy prescribing powers to treat UTIs in South Australia "is not the right call".
-
Butler to ‘monitor’
Wednesday | May 3 2023SPEAKING at the National Press Club in Canberra yesterday, Federal Health Minister Mark Butler said his dept would only "monitor" the impact of the 60-day medication policy.
-
Stelara on PBS
Wednesday | May 3 2023AUSTRALIAN adults with moderate-to-severe ulcerative colitis will now have subsidised access to a new treatment option, known as Stelara (ustekinumab), via the PBS.
